IQVIA Holdings Inc. (IQV) Financials

IQV Assets vs Liabilities

DateAssetsLiabilities
June 30, 2026 29.9 billion 23.6 billion
March 31, 2026 29.7 billion 23.3 billion
Dec. 31, 2025 29.9 billion 23.3 billion
Sept. 30, 2025 28.7 billion 22.4 billion

IQV Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 360.0 million 95.0 million
March 31, 2026 491.0 million 65.0 million
Dec. 31, 2025 561.0 million 60.0 million
Sept. 30, 2025 1.2 billion 55.0 million

IQV Net Income

Graph available only for paid members. Upgrade to see it.
DateNet Income
June 30, 2026 258.0 million
March 31, 2026 275.0 million
Dec. 31, 2025 514.0 million
Sept. 30, 2025 332.0 million

IQV Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 2.1 billion 13.7 billion 242.0 million
March 31, 2026 1.9 billion 14.0 billion 232.0 million
Dec. 31, 2025 2.1 billion 14.1 billion 225.0 million
Sept. 30, 2025 2.0 billion 12.8 billion 233.0 million

IQV Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 168.6 million
March 31, 2026 169.8 million
Dec. 31, 2025 171.9 million
Sept. 30, 2025 171.7 million

IQV Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 198.0 million - 574.0 million -
March 31, 2026 127.0 million - 502.0 million -
Dec. 31, 2025 174.0 million - 468.0 million -
Sept. 30, 2025 293.0 million - 514.0 million -

IQV Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 4.4 billion 2.9 billion
March 31, 2026 4.2 billion 2.8 billion
Dec. 31, 2025 4.4 billion 4.1 billion
Sept. 30, 2025 4.1 billion 2.7 billion

IQV Revenue by Segment

Graph available only for paid members. Upgrade to see it.

IQV

Price: $267.77

52 week price:
154.50
271.62

Payout Ratio Range:
-358.43%
6064.86%

Earnings Per Share: 8.04 USD

P/E Ratio: 29.23

Exchange: NYQ

Sector: Healthcare

Industry: Diagnostics & Research

Country: United States

Volume: 286158

Market Capitalization: 43.4 billion

Links: